Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent,RMP-7: A toxicologic evaluation in swine

RMP-7 is a bradykinin B2 receptor agonist shown to permeabilize the blood-brain barrier, especially that associated with brain tumors, when administered via both intracarotid and intravenous routes. Both routes of administration are currently being tested in human trials in combination with the chemotherapeutic agent carboplatin as therapy for gliomas. As an essential prerequisite to the initial intracarotid clinical trials, the potential neurotoxicity of intra-arterial administration of RMP-7 (at a high or low dose), alone and in combination with carboplatin, was assessed in anesthetized Red Duroc swine. Five treatment groups were evaluated with each pig receiving a series of alternating, intra-arterial infusions of RMP-7 (or saline) followed by carboplatin (or saline), as follows: (1) vehicle control: saline/saline; (2) carboplatin only control: saline/carboplatin (50 mg total); (3) RMP-7 only control: RMP-7 (750 ng/kg)/saline; (4) low dose combination: RMP-7 (75 ng/kg)/carboplatin (50 mg total); and (5) high dose combination: RMP-7 (750 ng/kg)/carboplatin (50 mg total). For each subject, one of the alternating dosing sequences (above) was repeated four times during a single dosing session which lasted approximately 40 minutes. Assessments during the in-life phase of the study in the pre- and post-treatment periods consisted of heart rate, arterial blood pressure (systolic, diastolic, and mean), blood gases, body weight, general clinical observations (including evaluation for neurological deficit) and clinical pathology (including a comprehensive battery of standard blood coagulation, hematological and serum chemistry tests). In addition, during the time of treatment, heart rate and arterial blood pressure were monitored. The animals were terminated two weeks after dosing and the brain and rete mirabile (distal to site of infusion) were evaluated for gross and histopathological abnormalities. The histopathology analysis included a reader-blinded analysis using low and high power light microscopic examination of both H&E and Kluver-Berrera stained sections through several key cortical and subcortical brain regions. Transient decreases in arterial blood pressure (mean of 10–25 mmHg) were observed in both groups receiving the high dose of RMP-7 (i.e., 750 ng/kg). No other side effects attributable to RMP-7 and/or carboplatin were observed, and clinical observations revealed no evidence of neurologic deficits. Post-mortem examination revealed no evidence of CNS or cerebral vascular pathology attributable to carboplatin and RMP-7. This study demonstrates that intracarotid administration of the maximum tolerated dose of RMP-7 (750 ng/kg) alone, or in combination with carboplatin (50 mg) is not accompanied by any serious adverse effect, apparent cerebrovascular abnormality or neuropathologic consequence and offers further evidence for the safety of this novel therapeutic approach for enhancing delivery of chemotherapeutics to brain tumors.     

Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors

Preterm children who develop severe chronic lung disease may be developmentally compromised by exposure to hypoxic episodes. This study aims to determine if children with severe bronchopulmonary dysplasia (BPD) who required home oxygen therapy were at greater risk for neurological and motor deficits at school age than preterm peers without BPD. This study evaluated 27 subjects with BPD and 27 preterm control infants matched for gestational age, birthweight, sex, and year of birth at a mean age of 9.9 years (2.0 SD) using standardized neuromotor outcome measures. Pair-matched comparisons and regression analyses were used to determine if subjects with BPD were at increased risk for neuromotor sequelae. Neurological abnormalities, including subtle neurological signs, cerebral palsy, microcephaly, and behavioral difficulties were highly prevalent in the BPD group (71% compared with 19% in control group, P<0.005). Over half the BPD cohort had difficulties in gross and/or fine motor skills. There were significant differences in postural stability between groups. Duration of hospitalization and home oxygen treatment, and decreased lung function at school age, markers of severity of illness, correlated with motor outcomes. The findings underline the importance of preventing the cardiorespiratory complications associated with chronic lung disease to minimize disability in preterm children. For children with severe BPD, better recognition and subsequent remediation of neuromotor impairments that manifest at school age may help maximize their functional potential.     

Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization

OBJECTIVES: This study tested the hypothesis that a recombinant human C5a antagonist, CGS 32359, attenuates neutrophil activation and reduces infarct size in a porcine model of surgical revascularization. METHODS: CGS 32359 (0.16-16 micromol/L) dose-dependently inhibited superoxide production by human C5a-activated porcine neutrophils (18 +/- 3.7 vs 1.6 +/- 0.5 nmol/5 min/5 x 10(6) neutrophils; P <.05) and reduced neutrophil adherence to coronary endothelium from 194 +/- 9 to 43 +/- 6 neutrophils/mm(2) (P <.05). The left anterior descending coronary artery was occluded for 50 minutes, after which saline solution (n = 8), mannitol-buffer vehicle (n = 9, 102 mg/kg bolus, 102 mg. kg(-1). h(-1)), or CGS 32359 (CGS, n = 7, 60 mg/kg bolus, 60 mg. kg(-1). h(-1)) was infused. After ischemia, 1-hour arrest was achieved by means of multidose hypothermic (4 degrees C) blood cardioplegia, followed by 2.5 hours of off-bypass reperfusion. The ligature on the left anterior descending artery was released before the second infusion of cardioplegic solution. RESULTS: Area at risk was similar in all groups (saline solution, 27% +/- 2%; mannitol-buffer vehicle, 26% +/- 2%; CGS, 26% +/- 2% left ventricular mass). Infarct size (area necrosis/area at risk) was significantly reduced by CGS (18% +/- 6%, P <.05) versus saline solution (52% +/- 3%) and mannitol-buffer vehicle (60% +/- 4%). Postischemic systolic shortening (sonomicrometry) in the area at risk was significantly improved with CGS (0.8% +/- 0.9%) compared with saline solution (-3.7% +/- 1.1%) and mannitol-buffer vehicle (-6.4% +/- 1.0%). Myeloperoxidase activity from accumulated neutrophils was less in the ischemic zone of CGS (0.014 +/- 0.002 U/100 mg tissue; P <.05) than mannitol-buffer vehicle (0.133 +/- 0.012 U/100 mg tissue). CONCLUSIONS: We conclude that the recombinant human C5a receptor antagonist CGS 32359 inhibits surgical ischemia-reperfusion injury after coronary occlusion.     

Effects of hindlimb unloading on neuromuscular development of neonatal rats

We hypothesized that hindlimb suspension unloading of 8-day-old neonatal rats would disrupt the normal development of muscle fiber types and the motor innervation of the antigravity (weightbearing) soleus muscles but not extensor digitorum longus (EDL) muscles. Five rats were suspended 4.5 h and returned 1.5 h to the dam for nursing on a 24 h cycle for 9 days. To control for isolation from the dam, the remaining five littermates were removed on the same schedule but not suspended. Another litter of 10 rats housed in the same room provided a vivarium control. Fibers were typed by myofibrillar ATPase histochemistry and immunostaining for embryonic, slow, fast IIA and fast IIB isomyosins. The percentage of multiple innervation and the complexity of singly-innervated motor terminal endings were assessed in silver/cholinesterase stained sections. Unique to the soleus, unloading accelerated production of fast IIA myosin, delayed expression of slow myosin and retarded increases in standardized muscle weight and fiber size. Loss of multiple innervation was not delayed. However, fewer than normal motor nerve endings achieved complexity. Suspended rats continued unloaded hindlimb movements. These findings suggest that motor neurons resolve multiple innervation through nerve impulse activity, whereas the postsynaptic element (muscle fiber) controls endplate size, which regulates motor terminal arborization. Unexpectedly, in the EDL of unloaded rats, transition from embryonic to fast myosin expression was retarded. Suspension-related foot drop, which stretches and chronically loads EDL, may have prevented fast fiber differentiation. These results demonstrate that neuromuscular development of both weightbearing and non-weightbearing muscles in rats is dependent upon and modulated by hindlimb loading.     

Lumbar epidural morphine in humans and supraspinal analgesia to experimental heat pain

BACKGROUND: Epidural administration of morphine is a common analgesic technique to manage pain. Morphine spreads from the epidural space to the cerebrospinal fluid and then rostrally, causing side effects mediated by the brain stem. However, data on the rostral spread of morphine-mediated analgesia are sparse. This study examined the rostral spread of analgesic effects on heat and electrical pain after epidural administration of morphine. METHODS: In a randomized, double-blinded, placebo-controlled, crossover study, 5 mg morphine or saline placebo were injected into the lumbar epidural space in nine healthy volunteers. Correct needle placement was confirmed with fluoroscopy. Analgesia to experimental nociceptive heat and electrical stimuli was measured at lumbar (L4), thoracic (T10), cervical (C2), and trigeminal (V2) levels before and 2, 5, 10, and 24 h after epidural injection. Plasma samples for assaying morphine concentrations were drawn before and after each analgesic evaluation. RESULTS: Epidural morphine significantly attenuated experimental heat pain at all dermatomes tested compared with saline placebo. Analgesic effects were significant at L4 after 2, 5, and 10 h, at T10 after 5, 10, and 24 h, and at V2 after 10 h. Electrical pain was attenuated at the lumbar and thoracic but not at the cervical dermatome. Analgesic effects were significant at L4 after 2, 5, and 10 h and at T10 after 5 and 10 h. Morphine plasma concentrations were below the detection limit (1 ng/ml) in eight of the nine subjects 10 h after epidural injection. CONCLUSIONS: Lumbar epidural injection of morphine attenuated cutaneous heat pain up to the trigeminal dermatome during a 24-h observation period. In a clinical context, this implies that some types of pain may be attenuated up to the supraspinal level after lumbar epidural administration of morphine.     

The effects of sucrose on stability of human brain natriuretic peptide [hBNP (1–32)] and human parathyroid hormone [hPTH (1–34)]

Abstract: Although the effect of sucrose on the physical stability of proteins has been well documented, its impact on their chemical stability is largely unknown. The aim of this study was to investigate the potential effects of sucrose on the structural conformation of human brain natriuretic peptide [hBNP (1–32)] and the synthetic human parathyroid hormone [hPTH (1–34)], and link these effects to chemical degradation pathways of these peptides. The stability of hBNP (1–32) and hPTH (1–34) was studied at pH 5.5. Aggregation was monitored using size exclusion high‐performance liquid chromatography (SE‐HPLC), whereas oxidation and deamidation products were measured by reversed phase (RP) HPLC. Fourier transform infrared (FT‐IR) spectroscopy was used to study the peptides’ conformation. Sucrose retarded aggregation, deamidation, and oxidation of hBNP (1–32) and hPTH (1–34), with a maximum effect at relatively high concentrations (as much as 1 m ). FT‐IR spectroscopy indicated that sucrose maintained the native conformation of hBNP (1–32) and induced small conformation changes in the hPTH (1–34) structure. Sucrose enhanced the stability of hBNP (1–32) and hPTH (1–34) in liquid formulations. The stabilizing effect of sucrose was due to a large extent to retardation of oxidation and deamidation of hBNP (1–32) and hPTH (1–34).     

Strong methane point sources contribute a disproportionate fraction of total emissions across multiple basins in the United States

Understanding, prioritizing, and mitigating methane (CH₄) emissions requires quantifying CH₄ budgets from facility scales to regional scales with the ability to differentiate between source sectors. We deployed a tiered observing system for multiple basins in the United States (San Joaquin Valley, Uinta, Denver-Julesburg, Permian, Marcellus). We quantify strong point source emissions (>10 kg CH₄ h⁻¹) using airborne imaging spectrometers, attribute them to sectors, and assess their intermittency with multiple revisits. We compare these point source emissions to total basin CH₄ fluxes derived from inversion of Sentinel-5p satellite CH₄ observations. Across basins, point sources make up on average 40% of the regional flux. We sampled some basins several times across multiple months and years and find a distinct bimodal structure to emission timescales: the total point source budget is split nearly in half by short-lasting and long-lasting emission events. With the increasing airborne and satellite observing capabilities planned for the near future, tiered observing systems will more fully quantify and attribute CH₄ emissions from facility to regional scales, which is needed to effectively and efficiently reduce methane emissions.

Due to its short atmospheric lifetime and strong contribution to global radiative forcing, methane (CH₄) has been a focus for near-term climate mitigation efforts (1). Robust, unbiased accounting systems are requisite to prioritizing and validating CH₄ mitigation, ideally from multiple independent data streams. Atmospheric observations of CH₄ can be key for mitigation, as observed CH₄ concentrations are used to quantify emission rates and attribute emissions to sources. Findings from many independent research efforts have shown that CH₄ emissions across multiple sectors follow heavy-tailed distributions (2–5), meaning that a small fraction of emission sources emits at disproportionately higher rates than the full population of emitters. CH₄ sources can be intermittent or persistent in duration, which may be associated with short-lasting process-driven releases or long-lasting emissions due to abnormal or otherwise avoidable operating conditions such as malfunctions or leaks (5). Isolating populations of large emitters at varying levels of intermittency while quantifying their contribution to regional budgets creates a clear direction for mitigation focus. This tiered observing system strategy can be deployed in data-rich regions where multiple independent layers of observations are jointly leveraged to quantify and isolate emissions, and then drive action.Advances in CH₄ remote sensing have enabled quantification of emissions from global to facility scales. Generally, these observing systems operate by measuring solar backscattered radiance in shortwave infrared regions where CH₄ is a known absorber. Global mapping satellite missions have been used to identify CH₄ hotspots and infer global- to regional-scale CH₄ emission fluxes (6–8). In particular, the TROPOspheric Monitoring Instrument [TROPOMI (9)] onboard the Sentinel-5p satellite has proven capable of quantifying fluxes at basin scales (10, 11). Due to the kilometer-scale resolution of measurements from these global mapping missions, further attribution to particular facilities or even emission sectors is often not feasible. Less precise, target-mode satellites [e.g., PRISMA (12), GHGSat (13)] have proven capable of quantifying very large emissions at an ∼30-m scale, allowing for direct emission attribution to facilities or even subfacility-level infrastructure. However, the current generation of CH₄ plume imaging satellites lack the spatial and temporal coverage to provide quantification completeness across multiple basins. For global mapping, high–spatial resolution multispectral satellites such as Sentinel-2 and Landsat are capable of CH₄ detection (14, 15), but only for large emission sources (e.g., 2+ t h⁻¹) over very bright surfaces.Airborne imaging spectrometers with shortwave infrared sensitivities and sufficient instrument signal-to-noise ratios can also quantify column CH₄ concentrations. These remote sensing platforms are capable of resolving CH₄ concentrations at high spatial resolution (∼3 to 5 m) depending on flight altitude, and can quantify point source emissions as low as 5 to 10 kg h⁻¹ (16, 17). These instruments are sensitive to concentrated point-source emissions, and less sensitive to diffuse emissions spread over large areas (e.g., wetlands). Given the heavy-tailed nature of anthropogenic emissions, point-source detections above an imaging spectrometer’s detection limit may constitute a sizable fraction of the total regional CH₄ flux, but independent measurements are needed to provide that context. Therefore, in this study, we flew a combination of the Global Airborne Observatory (GAO) and next-generation Airborne Visible/Infrared Imaging Spectrometer (AVIRIS-NG) over multiple CH₄ emitting regions between 2019 and 2021, including the southern San Joaquin Valley (SJV), the Permian, the Denver-Julesburg (DJ), the Unita, and the southwestern Pennsylvania portion of the Marcellus. We generally mapped each basin at least three times during each campaign to quantify persistence of emission sources. For the Permian, DJ, and SJV, we surveyed each region again after several months to assess trends and identify long-lasting emission sources. We also performed simultaneous regional CH₄ flux inversions based on TROPOMI CH₄ retrievals to quantify the total CH₄ flux for each survey and compared against the quantified airborne point source budgets. With this tiered approach, we are able to quantify the contribution of unique point sources by sector on the regional budget, therefore highlighting specific points of action for mitigation.     

Comparing the development of cortex-wide gene expression patterns between two species in a common reference frame

Advances in sequencing techniques have made comparative studies of gene expression a current focus for understanding evolutionary and developmental processes. However, insights into the spatial expression of genes have been limited by a lack of robust methodology. To overcome this obstacle, we developed methods and software tools for quantifying and comparing tissue-wide spatial patterns of gene expression within and between species. Here, we compare cortex-wide expression of RZRβ and Id2 mRNA across early postnatal development in mice and voles. We show that patterns of RZRβ expression in neocortical layer 4 are highly conserved between species but develop rapidly in voles and much more gradually in mice, who show a marked expansion in the relative size of the putative primary visual area across the first postnatal week. Patterns of Id2 expression, by contrast, emerge in a dynamic and layer-specific sequence that is consistent between the two species. We suggest that these differences in the development of neocortical patterning reflect the independent evolution of brains, bodies, and sensory systems in the 35 million years since their last common ancestor.

Almost everything we know about the human brain comes from comparative studies of other animals: from genes involved in cortical development to system-level networks that generate complex behaviors. Comparative studies of living species provide a robust means by which to understand unknown forms, like humans, and even extinct forms like our early mammalian ancestors. Importantly, these types of studies are critical for identifying features of brain organization that are conserved between species and those that may have been derived in different lineages. They also allow us to determine how developmental programs and timing schedules may vary across species, and to better understand how phenotypic diversity can be generated over shorter and longer timescales. Finally, by making valid comparisons across species, we can begin to understand how complexity emerges in different nervous systems, the rules of brain construction, and the constraints imposed on developing and evolving nervous systems.Despite the importance of comparative studies in biology, most comparisons of anatomically reconstructed data are subjective, and most gene sequencing studies neglect the actual spatial patterns of gene expression across a structure, focusing instead on cell-type expression (1–3). Moreover, many current methods for making comparisons fail to capture the three-dimensional nature of the brain, which is composed of asymmetrical structures that can vary markedly in relative shape, size, and location across species and between developmental time-points. Despite the three-dimensional (3D) nature of the brain, most studies collapse data into two dimensions driven largely by the plane of section at which the brain is cut.As such, neurobiologists are faced with two challenges. First, attempting to understand 3D structures by analyzing two-dimensional (2D) images is inherently problematic because the loss of spatial information is unavoidable, especially in curved structures (4). 2D analysis often involves prespecifying regions of interest (ROIs) to quantify the presence of labeled cells or mRNA expression after in-situ hybridization (ISH), narrowing the focus and potentially missing overall differences across a structure, such as the neocortex. A second challenge, which arises when making comparisons between structures in different species and/or at different developmental time-points, or between different experimental conditions, is determining the extent to which 2D spatial patterning might be invariant to basic transformations in the size and shape of the 3D structure. To this end, it is important for comparisons to be made with respect to a common anatomical reference frame.In the current study, we overcame these challenges by developing a set of algorithms for brain slice registration in 3D, and for incorporating ISH data into a common reference frame to enable point-by-point comparisons between species or experimental conditions (see Materials and Methods). These tools, which we refer to collectively as Stalefish, the Spatial Analysis of Fluorescent (and nonfluorescent) In-Situ Hybridization, allowed for the laminar and spatial patterns of expression of genes involved in cortical development to be quantified and compared in two species of age matched rodents across early postnatal development. Our analysis of Id2 and RZRβ cortical expression patterns in mouse and vole brains reveals both a strong layer-specific conservation of the patterning of these genes, as well as area-specific differences in development that shed new light on the ontogeny and phylogeny of neocortical arealization.